Hutchmed China CFO Cheng is interim CEO as CEO Su takes health leave
26th Aug 2025 09:14
(Alliance News) - Hutchmed China Ltd on Tuesday said Chief Executive Officer Weiguo Su will take a leave of absence for health reasons. Read More
| Price | 218.00p on 04-09-2025 at 13:33:27 |
|---|---|
| Change | -9.50p -4.18% |
| Buy | 219.00p |
| Sell | 215.00p |
| Last Trade: | Sell 5,200.00 at 215.052p |
| Day's Volume: | 8,839 |
| Last Close: | 227.50p |
| Open: | 222.00p |
| ISIN: | KYG4672N1198 |
| Day's Range | 218.00p - 222.00p |
| 52wk Range: | 187.50p - 336.00p |
| Market Capitalisation: | £1.87b |
| VWAP: | 216.76434p |
| Shares in Issue: | 859.30m |
Sector: Medicine and Biotech
Listed In: FTSE AIM 100, FTSE AIM All-Share,
Hutchmed (HCM) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 5,200 | 215.052p | Ordinary |
14:33:25 - 04-Sep-25 |
| Buy* | 636 | 218.60p | Ordinary |
14:32:39 - 04-Sep-25 |
| Buy* | 10 | 219.00p | Ordinary |
14:27:50 - 04-Sep-25 |
| Buy* | 750 | 218.60p | Ordinary |
14:26:25 - 04-Sep-25 |
| Buy* | 20 | 219.00p | Ordinary |
14:18:30 - 04-Sep-25 |
| Buy* | 100 | 220.00p | SI Trade |
14:17:51 - 04-Sep-25 |
| Sell* | 250 | 218.00p | Automatic Execution |
14:17:51 - 04-Sep-25 |
| Sell* | 1,100 | 219.00p | Automatic Execution |
13:02:14 - 04-Sep-25 |
| Sell* | 601 | 222.00p | Automatic Execution |
08:52:21 - 04-Sep-25 |
| Sell* | 287 | 223.00p | Automatic Execution |
16:29:59 - 03-Sep-25 |
Hutchmed (HCM) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 26th Aug 2025 7:00 am | RNS | Directorate Change |
| 20th Aug 2025 7:00 am | RNS-R | HUTCHMED Completes Enrollment of Phase III Trial |
| 7th Aug 2025 12:00 pm | RNS | 2025 Interim Results |
| 3rd Jul 2025 9:30 am | RNS | HUTCHMED to Announce 2025 Half-Year Results |
| 2nd Jul 2025 10:00 am | RNS | Update on Joint Corporate Brokers in London |
| 30th Jun 2025 9:30 am | RNS | China Approval based on Phase III SACHI Trial |
| 30th Jun 2025 9:30 am | RNS | Total Voting Rights |
| 30th Jun 2025 9:30 am | RNS | Blocklisting Six Monthly Return |
| 10th Jun 2025 11:00 am | RNS | Grant of Share Options and Awards under LTIP |
| 5th Jun 2025 7:00 am | RNS-R | HUTCHMED and Innovent Announce NDA Acceptance |